Skip to content

Clinical trials

Completed Lung Neoplasms trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Neoplasms Status: Completed Country / region: Italy Clear all

126 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20012
20021
20032
20044
20051
20065
20073
20086
20096
20105
20115
20128
20137
20145
201514
20167
20178
20182
20196
20204
20216
20221
20234
20241
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed126

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals9
AstraZeneca8
European Organisation for Research and Treatment of Cancer - EORTC8
Bristol-Myers Squibb6
Amgen4
University of Milan4
Celgene3
European Institute of Oncology3
Fondazione Policlinico Universitario Agostino Gemelli IRCCS3
Genzyme, a Sanofi Company3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Neoplasms126
Carcinoma, Non-Small-Cell Lung50
Neoplasms17
Breast Neoplasms13
Adenocarcinoma of Lung10
Carcinoma7
Colorectal Neoplasms7
Neoplasm Metastasis7
Urinary Bladder Neoplasms6
Head and Neck Neoplasms5

Trials

Showing 1 to 25 of 126. Each trial links to its page on Pharma Observatory.

26 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.